Matteo del Brocco

Analyst in Residence @Healthtech Capital

Pittsburgh, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2025 — Present

Analyst in Residence @Healthtech Capital

View department →

Conduct due diligence on early-stage healthcare and life sciences companies, assessing technology, market dynamics, and commercial potential.Synthesize technical, clinical, and business inputs into structured analyses to support investment and strategic decisions.Collaborate with cross-functional teams to evaluate risk, differentiation, and scalability across healthcare markets.

EDUCATION

N/A

University of Pittsburgh Swanson School of Engineering

Doctor of Philosophy - PhD, Bioengineering and Biomedical Engineering

2012 — 2018

University of Rome Tor Vergata

Bachelor of Science - BS, Biomedical/Medical Engineering

2018 — 2021

Sapienza Università di Roma

Master of Science - MS, Biomedical/Medical Engineering

ABOUT MATTEO DEL BROCCO

I am a life sciences and healthcare consultant with experience supporting strategy, operations, and analytics-driven decision-making in complex, regulated environments. My background combines hands-on consulting engagements with applied research, enabling me to translate technical, clinical, and market information into clear insights that inform business and organizational decisions.I have worked on portfolio optimization, commercialization and market assessment, operational improvement, and due diligence initiatives across healthcare and life sciences organizations. In these roles, I’ve partnered with cross-functional stakeholders, conducted structured analyses, and contributed to client-facing recommendations focused on prioritization, efficiency, and growth.I am currently completing a Ph.D. in Bioengineering at the University of Pittsburgh, where my work emphasizes quantitative analysis, experimental design, and decision-making under uncertainty. I am particularly interested in consulting and strategy roles at the intersection of science and business, with anticipated availability beginning in mid-2026.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.